Biotin-free systems provide stronger immunohistochemical signal in oestrogen receptor evaluation of breast cancer

Journal of Clinical Pathology

Volumn 62, Issue 8, 2009, Pages 699-704

  Rocha, Rafael Malagoli ^a,b,c,e   Miller, K ^b   Soares, F ^c   Schenka, N ^d   Vassallo, J ^c,d   Gobbi, H ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c A C CAMARGO CANCER CENTER   (Brazil)

^d UNIVERSITY OF CAMPINAS   (Brazil)

^e NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTIN; ESTROGEN RECEPTOR;

ADULT; AGED; ARTICLE; BIOTIN FREE POLYMERIC VISUALISATION SYSTEM; BREAST CARCINOMA; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; STREPTAVIDIN BIOTIN SYSTEM; TISSUE MICROARRAY;

ADULT; AGED; BIOTIN; BREAST NEOPLASMS; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; MIDDLE AGED; NEOPLASM PROTEINS; RECEPTORS, ESTROGEN; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 68149183615     PISSN: 00219746     EISSN: 14724146     Source Type: Journal    
DOI: 10.1136/jcp.2009.065326     Document Type: Article

References (22)

1. King G, Payne S, Walker F, et al. A highly sensitive detection method for immunohistochemsitry using biotinylated tyramine. J Pathol 1997;183:237-241 (Pubitemid 27436031)
2. Petrosyan K, Tamayo R, Joseph D. Sensitivity of a novel biotin-free detection reagent (Powervision+y) for immunohistochemistry. J Histotechnol 2002;25:247-250 (Pubitemid 36043328)
3. Shi SR, Gu J, Kalra KL, et al. Antigen retrieval technique: a novel approach to immunohistochemistry on routinely processed tissue sections. Cell Vision 1995;2:6-22.
4. Sabattini E, Bisgaard K, Ascani S, et al. The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques. J Clin Pathol 1998;51:506-511 (Pubitemid 28375029)
5. Vassallo J, Pinto GA, Alvarenga M, et al. Comparison of immunoexpression of two antibodies for estrogen receptors (1D5 and 6F11) in breast carcinomas using different antigen retrieval and detection methods. Appl Immunohistochem 2004;12:177-182 (Pubitemid 38796461)
6. von Wasielewski R, Mengel M, Wiese B, et al. Tissue array technology for testing interlaboratory and interobserver reproducibility of immunohistochemical estrogen receptor analysis in a large multicenter trial. Am J Clin Pathol 2002;118:475-482 (Pubitemid 37046311)
7. Bacus S, Flowers JL, Press MF, et al. The evaluation of estrogen receptor in primary breast carcinoma by computer-assisted image analysis. Am J Clin Pathol 1988;90:233-239 (Pubitemid 18211051)
8. Gokhale S, Rosen D, Sneige N, et al. Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma. Appl Immunohistochem 2007;15:451-455 (Pubitemid 350307853)
9. McClelland RA, Wilson D, Leake R, et al. A multicentre study into the reliability of steroid receptor immunocytochemical assay quantification. Eur J Cancer 1991;27:711-715
10. Harvey JN, Clarck GM, Osborne CK, et al. Estrogen receptor status by immunohistochemistry is superior to the ligand binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481
11. Cheang MCU, Treaba DO, Speers CH, et al. Immunohistochemical detection using the new rabbit monoclonal antibody SP1 of estrogen receptor in breast cancer is superior to mouse monoclonal antibody 1D5 in predicting survival. J Clin Oncol 2006;24:5637-5644
12. Gouvea AP, Milanezi F, Olson SJ, et al. Selecting antibodies to detect HER2 overexpression by immunohistochemistry in invasive mammary carcinomas. Appl Immunohistochem 2006;14:103-108
13. Nunes CB, Rocha RM, Reis-Filho JS, et al. Comparative analysis of six different antibodies against Her2 including the novel rabbit monoclonal antibody (SP3) and chromogenic in situ hybridisation in breast carcinomas. J Clin Pathol 2008;61:934-938
14. Rocha RM, Nunes CB, Rocha GFS, et al. Rabbit monoclonal antibodies show higher sensitivity than mouse monoclonals for estrogen and progesterone receptor evaluation in breast cancer by immunohistochemistry. Pathol Res Prac 2008;204:655-662
15. Cattoretti G, Pileri S, Parravicini C, et al. Antigen unmasking on formalin-fixed, paraffin-embedded tissue sections. J Pathol 1993;171:83-98. (Pubitemid 23309729)
16. Rhodes A, Jasani B, Couturier J, et al. A formalin-fixed, paraffin-processed cell line standard for quality control of immunohistochemical assay of HER-2/neu expression in breast cancer. Am J Clin Pathol 2002;117:81-89 (Pubitemid 34052476)
17. Fisher B, Redmond C, Fisher ER, et al. Relative worth of estrogen or progesterone receptor and pathologic characteristics of differentiation as indicators of prognosis in node negative breast cancer patients: findings from National Surgical Adjuvant and Bowel Project Protocol B-06. J Clin Oncol 1988;7:1076-1087
18. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. J Clin Oncol 2001;19:3817-3827 (Pubitemid 32880060)
19. Walker RA. Immunohistochemical markers as predictive tools for breast cancer. J Clin Pathol 2008;61:689-696 (Pubitemid 351859960)
20. Kim SH, Kook MC, Shin YK, et al. Evaluation of antigen retrieval buffer systems. J Mol Histol 2004;35:409-416
21. Wood GS, Warnke R. Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems. J Histochem Cytochem 1981;29:1196-1204 (Pubitemid 11061054)
22. Umemura S, Itoh J, Itoh H, et al. Immunohistochemical evaluation of hormone receptors in breast cancer: which scoring system is suitable for highly sensitive procedures? Appl Immunohistochem 2004;12:8-13.